Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
J Pharmacol Sci. 2013;122(2):109-17. doi: 10.1254/jphs.13019fp. Epub 2013 May 24.
Accumulating lines of evidence showed that luteolin, a polyphenolic compound, has potent neuroprotective effects. The purpose of this study was to examine whether luteolin can protect against sodium nitroprusside (SNP)-induced oxidative damage in mouse brain. Intrastriatal co-injection of luteolin (3 - 30 nmol) with SNP (10 nmol) dose-dependently protected against brain damage and motor dysfunction. Oral administrations of luteolin (600 - 1200 mg/kg) dose-dependently protected against brain damage and motor dysfunction induced by striatal injection of SNP. Furthermore, luteolin (30 - 100 μM) concentration dependently protected against Fe(2+)-induced lipid peroxidation in mouse brain homogenate. Luteolin (1 - 100 μg/ml) showed potent DPPH radical scavenging ability, when compared with ascorbic acid and glutathione. Finally, a ferrozine assay showed that luteolin (30 - 100 μg/ml) has Fe(2+)-chelating ability, but this was weaker than that of ethylenediaminetetraacetic acid. These results suggest that intrastriatal or oral administration of luteolin protected mice brain from SNP-induced oxidative damage by scavenging and chelating effects.
越来越多的证据表明,木犀草素是一种多酚化合物,具有很强的神经保护作用。本研究旨在探讨木犀草素是否能预防硝普钠(SNP)诱导的小鼠脑氧化损伤。纹状体内共注射木犀草素(3-30 nmol)与 SNP(10 nmol)呈剂量依赖性保护对抗脑损伤和运动功能障碍。口服木犀草素(600-1200 mg/kg)可剂量依赖性地对抗 SNP 诱导的纹状体注射引起的脑损伤和运动功能障碍。此外,木犀草素(30-100 μM)浓度依赖性地保护小鼠脑匀浆中 Fe(2+)诱导的脂质过氧化。与抗坏血酸和谷胱甘肽相比,木犀草素(1-100 μg/ml)表现出很强的 DPPH 自由基清除能力。最后,铁嗪测定表明,木犀草素(30-100 μg/ml)具有 Fe(2+)螯合能力,但弱于乙二胺四乙酸。这些结果表明,纹状体内或口服给予木犀草素通过清除和螯合作用保护小鼠大脑免受 SNP 诱导的氧化损伤。